Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Return on Capital Employed (2016 - 2025)

Neuroone Medical Technologies' Return on Capital Employed history spans 11 years, with the latest figure at 0.91% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 65.0% year-over-year to 0.91%; the TTM value through Dec 2025 reached 0.91%, up 65.0%, while the annual FY2025 figure was 0.73%, 190.0% up from the prior year.
  • Return on Capital Employed reached 0.91% in Q4 2025 per NMTC's latest filing, down from 0.5% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.5% in Q3 2025 to a low of 4.06% in Q3 2024.
  • Average Return on Capital Employed over 5 years is 1.61%, with a median of 1.22% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: crashed -307bps in 2021, then soared 356bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.95% in 2021, then grew by 4bps to 0.91% in 2022, then tumbled by -168bps to 2.43% in 2023, then skyrocketed by 36bps to 1.56% in 2024, then skyrocketed by 42bps to 0.91% in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Return on Capital Employed are 0.91% (Q4 2025), 0.5% (Q3 2025), and 0.91% (Q2 2025).